focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksInsig Ai Plc Regulatory News (INSG)

Share Price Information for Insig Ai Plc (INSG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12.75
Bid: 12.00
Ask: 13.50
Change: -0.50 (-3.77%)
Spread: 1.50 (12.50%)
Open: 13.25
High: 13.25
Low: 12.75
Prev. Close: 13.25
INSG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Admission to Aim and First Day of Dealings

10 May 2021 07:00

RNS Number : 0000Y
Insig AI Plc
10 May 2021
 

10 May 2021

Insig AI Plc

("Insig AI" or the "Company")

 

Admission to Aim and First Day of Dealings

Insig AI Plc (AIM: INSG), a leading AI and machine learning company serving the asset management industry, is pleased to announce its admission to trading on AIM ("Admission") following the reverse takeover of Catena Group plc.

 

The number of ordinary shares in issue immediately after Admission will be 98,653,174, giving the Company a market capitalisation of approximately £88 million based upon the closing share price of the Company of 89.0 pence per share on 7 May 2021. The Company has changed its name to Insig AI Plc and its TIDM to INSG, with dealings in the Company's shares commencing at 08.00 a.m. today, 10 May 2021.

 

About Insig AI

Insig AI (formerly Insight Capital) is a data science and machine learning solutions company that provides bespoke web-based applications, advanced analytical tools, and modern technology infrastructure to make machine learning accessible to investment professionals.

 

Insig AI's products and services provide the critical components needed for a modern, data-driven investing strategy, including data strategy development, technology & cloud infrastructure, data ingestion, machine learning and analytics, and data visualisation. 

 

The Company's product suite is designed to transform an asset manager's data infrastructure and machine learning capabilities to deliver actionable and measurable results. Specifically, the products are: 

 

· Insig Portfolio - a multi-asset data-science and machine learning platform designed to enhance investment strategies and enable portfolio interrogation and performance attribution while delivering actionable and explainable results.

 

· Insig ESG - A tool for developing and executing a data-led ESG investing strategy; providing credible, transparent and evidence-based scoring based upon standard or bespoke methodologies.

 

· Insig Data - A data transformation tool for cleaning, structuring and categorising proprietary and third-party data to enable machine learning and other data analytics via Insig or client applications.

 

· Insig Docs - A microservice application that intelligently extracts, tags and stores documents based and unstructured data using cutting edge text extraction and elastic database technology.

 

· Insig Exceleton - A tool that converts complex Excel spreadsheets into Python code, enabling an accelerated transition to a modern, machine learning and data analytics enabled strategy.

 

Admission Highlights:

 

· Successfully raised £6.1 million (before expenses) via a placing of 9,172,375 new ordinary shares at 67 pence per share, a 14 per cent. premium to the closing share price of the Company of 59 pence per share on 2 September 2020, being the last business day before the Company's ordinary shares were suspended from trading.

 

· The funds will be used by Insig AI to pay the cash consideration due to the vendors and for general working capital purposes, namely investing in Insig AI's team of developers, engineers and sales and marketing employees to accelerate product growth and business development activities.

 

Steve Cracknell, CEO, Insig AI Plc, said: "Our listing today will accelerate the development of Insig AI. We believe there is a huge market opportunity as the environment for asset managers and other investment professionals becomes more challenging with limited organic growth, volatile market returns, and pressure on fees. Technology can play a critical role in helping the asset management industry navigate these issues. Many in the asset management industry have hardly begun implementing AI solutions and capitalising on the potential analytical and profitability benefits. Data-rich financial services companies stand to benefit significantly to enhance investing strategies with data insights. We are confident in the future of Insig AI and our ability to deliver sustainable, long-term value to our shareholders."

 

For further information, please visit www.insg.ai, or contact:

 

Insig AI Plc

Steve Cracknell, CEO 

Via SEC Newgate

 

Zeus Capital Limited (Nominated Adviser & Broker)

David Foreman / Rishi Majithia / James Hornigold

 

 

+44 (0) 203 829 5000

SEC Newgate (Financial PR)

Robin Tozer / Tom Carnegie / Richard Bicknell

 

+44 (0) 7540 106 366

insigai@secnewgate.co.uk

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCFLFSDEIIAIIL
12
Date   Source Headline
2nd May 20247:00 amRNSShare subscription, director dealing and TVR
17th Apr 20247:00 amRNSDirector/PDMR Shareholding
4th Apr 20247:00 amRNSFunding facility, share allotment & PDMR dealing
2nd Apr 20247:00 amRNSTrading update & equity funding facility proposal
28th Dec 20237:00 amRNSInclusion within UN Environment Programme Tool
22nd Dec 20237:00 amRNSDirector/PDMR Shareholding
21st Dec 20237:00 amRNSDirector/PDMR Shareholding
20th Dec 20237:00 amRNSInterim results
28th Nov 20237:00 amRNSAppointment of investor relations adviser and TVR
27th Nov 20237:00 amRNSCorporate development adviser and TVR
15th Nov 20237:00 amRNSDisposal, Loan Conversion, New Project Win & TVR
30th Oct 20237:00 amRNSNew Product Launch
28th Sep 20237:00 amRNSAppointment of Strategic Adviser and TVR
15th Sep 20233:56 pmRNSResult of AGM
15th Sep 20237:00 amRNSAGM Statement
30th Aug 20237:00 amRNSDirector/PDMR Shareholding
24th Aug 20237:00 amRNSDirector/PDMR Shareholding
21st Aug 20237:00 amRNSDirector/PDMR Shareholding
15th Aug 20237:00 amRNSDirector/PDMR Shareholding
14th Aug 20237:00 amRNSFinal Results, Posting of Report and Notice of AGM
1st Aug 20234:42 pmRNSChange of Registered Office
31st Jul 20235:30 pmRNSTotal Voting Rights
4th Jul 20237:00 amRNSRevision of Convertible Loan Facility Agreement
19th May 20237:00 amRNSDirector/PDMR Shareholding
11th May 20237:00 amRNSDirector/PDMR Shareholding
28th Apr 20237:00 amRNSDirector/PDMR Shareholding and Total Voting Rights
25th Apr 20237:00 amRNSDeath of Director
24th Apr 20237:02 amRNSEquity subscription
24th Apr 20237:01 amRNSInsig AI Data & Technology Collaboration with FCA
24th Apr 20237:00 amRNSTrading and operations update
9th Mar 20237:00 amRNSInsig AI showcase Generative AI Product Capability
6th Feb 20237:00 amRNSGenerative AI Product Capability
16th Jan 20237:00 amRNSDirector/PDMR Shareholding
9th Jan 20237:00 amRNSConvertible Loan Facility Drawdown
28th Dec 20227:00 amRNSDirector/PDMR Shareholding
23rd Dec 20227:00 amRNSDirector Dealing
22nd Dec 20227:00 amRNSRevision of Convertible Loan Facility Agreements
21st Dec 20227:00 amRNSDirectors gift shares to Company treasury & TVR
19th Dec 20227:00 amRNSInterim Results
8th Nov 20227:00 amRNSDirector/PDMR Shareholding
7th Nov 20227:00 amRNSNew Contract Win
3rd Nov 20227:00 amRNSTrading update
26th Oct 20227:00 amRNSConvertible Loan Facility drawdown
17th Oct 20227:00 amRNSPartnership agreement with BRAIN
12th Oct 20227:00 amRNSConvertible Loan Facility Agreement and drawdown
30th Sep 202212:13 pmRNSResult of Annual General Meeting & General Meeting
30th Sep 20227:00 amRNSContract win
26th Sep 20227:00 amRNSConvertible Loan Facility drawdown
20th Sep 20227:00 amRNSChange of Registered Office
12th Sep 20227:00 amRNSConvertible Loan Facility Agreement
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.